iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Pharmaids Pharmaceuticals Ltd EGM

₹46.66
(-4.25%)
Jul 3, 2024|12:00:00 AM

Pharmaids Pharma CORPORATE ACTIONS

05/07/2023calendar-icon
04/07/2024calendar-icon
PurposeAnnouncement DateMeeting Date
EGM6 Jan 202431 Jan 2024
Outcome of the Board meeting held on saturday, 06 January 2024. The Board decided to convene the 01st Extra Ordinary General Meeting of the Company on Wednesday, January 31, 2024 at 11:30 A.M. through Video Conferencing (VC) / Other AudioVisual Means (OAVM), in compliance with the SEBI Circulars and MCA Circulars issued from time to time, allowing the Companies to hold the General Meeting through Video Conferencing / Other Audio-Visual Means. This is to inform that the Companys Extraordinary General Meeting is scheduled to be held on Wednesday, 31 January, 2024 at 11:30 A.M. through Video Conferencing/Other Audio Visual Means (VC/OAVM). we are attaching herewith Notice of the EGM and Explanatory Statement thereto. (As Per BSE Announcement Dated on 08/01/2024) Newspaper Advertisement of Notice of 01st Extraordinary General Meeting for the Financial year 2023-24 to be held on Wednesday, 31st January 2024, along with E-voting facility and cut-off date. (As per BSE Announcement Dated on 09/01/2024) EGM 31/01/2024 (As Per BSE Bulletin Dated on 18.01.2024) Proceedings of the Extraordinary general meeting held on 31st January 2024 at 11:30 a.m. through VC/OAVM (As Per BSE Announcement Dated on 31/01/2024) Voting results along with scrutiniser report of the 01st Extraordinary General Meeting for the Financial Year 2023-24 held on Wednesday, 31st January 2024 at 11:30 A.M. thorugh VC/OAVM. (As Per BSE Announcement Dated on 02/02/2024) This is to inform you that the shareholders of the company in their Extraordinary General Meeting held on Wednesday, 31st January 2024, approved the appointment of Dr. Shankarappa Nagaraja Vinaya Babu (DIN: 01373832) as Director and Chairman (Non executive & Non Independent Category) of the company. Intimation of Alteration in Object Clause and Capital Clause of the Memorandum of Association of the Company. (As Per BSE Announcement Dated on 09/02/2024)

Pharmaids Pharma: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Pharmaids Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.